Yunxia Zhang

Department of Hematology, Nanfang Hospital, Southern Medical University, China (People's Republic)

Poster(s):

• 1408 - Optimizing Time-Limited Therapy in Unfit CLL/SLL Patients: Orelabrutinib, Bendamustine, and Obinutuzumab Combination (OBG) Regimen